Where I see patients (1)
My reviews
Selected research
-
A Predictive Autoantibody Signature in Multiple Sclerosis.
medRxiv : the preprint server for health sciences
-
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses.
Journal of neurology, neurosurgery, and psychiatry
-
Family planning considerations in people with multiple sclerosis.
The Lancet. Neurology
Clinical trials
VIRtual Versus UsuAL In-office Care for Multiple Sclerosis (VIRTUAL-MS)
The primary outcome will be disability worsening in one of the Multiple Sclerosis Functional Composite components at 24 months. Worsening is defined as 20% worsening in Timed 25 foot walking speed (T25FW), 20% worsening in the 9 h...
Recruiting
Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
The primary objective is to evaluate the efficacy of BZA relative to placebo for reducing P100 latencies on full field transient pattern reversal visual evoked potentials (VEPs). In response to a visual stimulus, cortically genera...
Recruiting
4.9